Benign familial infantile epilepsy

From WikiMD's WELLNESSPEDIA


Benign familial infantile epilepsy
Synonyms Benign familial infantile seizures
Pronounce N/A
Specialty N/A
Symptoms Seizures in infants
Complications N/A
Onset Typically between 3 and 12 months of age
Duration Varies, often resolves by age 2
Types
Causes Genetic mutations, often in the PRRT2 gene
Risks Family history of similar seizures
Diagnosis Clinical evaluation, EEG, genetic testing
Differential diagnosis Febrile seizures, other forms of epilepsy
Prevention N/A
Treatment Often not required, antiepileptic drugs if necessary
Medication N/A
Prognosis Generally good, seizures often resolve without long-term effects
Frequency Rare
Deaths N/A


Benign Familial Infantile Epilepsy (BFIE) is a rare genetic disorder characterized by the onset of seizures in infancy. The condition is considered benign because most children outgrow the seizures by the age of 2 years. The term familial indicates that the condition often runs in families.

Symptoms[edit]

The primary symptom of BFIE is recurrent seizures that begin between the ages of 3 and 12 months. These seizures are often characterized by sudden jerking movements or spasms. Other symptoms may include febrile seizures, which are seizures triggered by a high fever, and developmental delay, although this is less common.

Causes[edit]

BFIE is caused by mutations in the PRRT2 gene. This gene provides instructions for making a protein that is involved in the function of nerve cells, particularly in the transmission of signals. Mutations in the PRRT2 gene disrupt this function, leading to the symptoms of BFIE.

Diagnosis[edit]

Diagnosis of BFIE is based on the characteristic symptoms, particularly the onset of seizures in infancy and a family history of the condition. Genetic testing can confirm a diagnosis by identifying a mutation in the PRRT2 gene.

Treatment[edit]

Treatment for BFIE primarily involves managing the seizures. This may include the use of anti-seizure medications, such as carbamazepine or phenobarbital. In most cases, treatment can be discontinued once the child outgrows the seizures.

Prognosis[edit]

The prognosis for individuals with BFIE is generally good. Most children outgrow the seizures by the age of 2 years and go on to develop normally. However, some individuals may continue to experience seizures into adulthood, and a small number may have developmental delay or learning difficulties.

See also[edit]

File:Plain DNA icon.svg
This article is a stub related to genetics. You can help WikiMD by expanding it!